Randomised prostate cancer screening trial: 20 year follow-up - Concepedia

Concepedia

Publication | Open Access

Randomised prostate cancer screening trial: 20 year follow-up

DOI Full Paper Access

162

Citations

21

References

2011

Year

Gabriel Sandblom, Eberhard Varenhorst, J Rosell, Owe Löfman, Per Carlsson

Abstract

After 20 years of follow-up the rate of death from prostate cancer did not differ significantly between men in the screening group and those in the control group. Trial registration Current Controlled Trials, ISRCTN06342431.

References

	Year	Citations
Screening and Prostate-Cancer Mortality in a Randomized European Study Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, New England Journal of Medicine	2009	4K
Mortality Results from a Randomized Prostate-Cancer Screening Trial Gerald L. Andriole, E. David Crawford, Robert L. Grubb, New England Journal of Medicine	2009	2.9K
The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research Jonas F. Ludvigsson, P Otterblad-Olausson, Birgitta U. Pettersson, European Journal of Epidemiology	2009	2.3K
The completeness of the Swedish Cancer Register – a sample survey for year 1998 Lotti Barlow, Kerstin Westergren, Lars Holmberg, Acta Oncologica	2008	1.2K
Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer Gerrit Draisma, Rob Boer, Suzie J. Otto, JNCI Journal of the National Cancer Institute	2003	1.1K
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial Jonas Hugosson, Sigrid Carlsson, Gunnar Aus, The Lancet Oncology UrologyCancer EpidemiologyCancer ScreeningMedicineOutcomes Research	2010	925
Natural History of Early, Localized Prostate Cancer Jan-Erik Johansson JAMA	2004	709
Radical Prostatectomy Versus Watchful Waiting in Localized Prostate Cancer: the Scandinavian Prostate Cancer Group-4 Randomized Trial Anna Bill‐Axelson, L. Holmberg, F. Filen, JNCI Journal of the National Cancer Institute	2008	601
Rethinking Screening for Breast Cancer and Prostate Cancer Laura J. Esserman JAMA UrologyPreventive MedicineCancer DetectionCancer ScreeningMedicine	2009	515
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer Eveline A.M. Heijnsdijk, Arno der Kinderen, Elisabeth M. Wever, British Journal of Cancer	2009	160

Page 1